Characteristic | ACPA-positive (n = 310) | ACPA-negative (n = 121) | Group difference |
---|---|---|---|
Female (number; %) | 208 (67%) | 89 (74%) | P = 0.1932 |
RF positive (number; %) | 244 (79%) | 47 (39%) | P <0.0012 |
Age (years) | 54.0 (46.0, 64.0) | 55.0 (47.0, 62.0) | P = 0.6611 |
Disease duration (months) | 2.00 (0.00, 5.00) | 1.00 (0.00, 4.00) | P = 0.1063 |
Larsen score | 7.50 (2.50, 21.25)* | 4.50 (1.00, 9.50) | P <0.0013 |
DAS28 | 5.72 (4.91, 6.73) | 5.96 (4.92, 6.85) | P = 0.3051 |
HAQ | 1.62 (1.00, 2.12) | 1.62 (1.12, 2.12) | P = 0.5953 |
EuroQol | 0.60 (0.15, 0.68) | 0.58 (0.08, 0.68) | P = 0.5523 |
SF-36 PCS | 28.68 (23.24, 35.95) | 28.70 (22.90, 35.56) | P = 0.7133 |
SF-36 MCS | 38.64 (27.65, 53.71) | 35.87 (25.37, 52.95) | P = 0.2173 |